Daniel J. Drucker, MD, professor of medicine and the Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology at the University of Toronto, and a senior scientist at the Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital in Toronto, Ontario, Canada, has been named editor-in-chief of Endocrine Reviews.
“It is truly an honor to lead a journal that is such a jewel in the world of scholarly publishing,” Drucker said. “Endocrine Reviews’ articles play a key role in ensuring cutting-edge research is leveraged to achieve meaningful advances in public health.”
Drucker’s laboratory studies the molecular biology and physiology of gut hormones, with a focus on the glucagon-like peptides. Drucker’s scientific studies have identified multiple novel mechanisms of hormone action, enabling the development of new drug classes for diabetes, obesity and intestinal failure.
A Fellow of the Royal Society, London, Drucker’s discoveries have been recognized by numerous scientific and medical societies. He has been honored with the Endocrine Society’s Clinical Investigator Award, the American Diabetes Association’s Banting Award, the Claude Bernard Award from the European Foundation for the Study of Diabetes, the Manpei Suzuki International Prize, the Rolf Luft Award from the Karolinska Institute, and the Harrington Prize for Innovation in Medicine.
Endocrine Reviews publishes comprehensive, authoritative and timely review articles balancing both experimental and clinical endocrinology themes. The journal features Essential Points summaries for each article and professionally-prepared illustrations that can be downloaded for presentations and teaching. The journal’s Impact Factor ranks among the top of the more than 100 journals in the “Endocrinology & Metabolism” category of Clarivate Analytics’ Journal Citation Reports.
Drucker’s term as editor-in-chief will begin July 1, 2018.
Be sure to follow Drucker’s tweets about the latest endocrine research at @DanielJDrucker.
Loading ...